Trading Signals: GBT Stock Price Prediction and Forecast (Wed. Aug. 12, 2015 - Tue. Oct. 4, 2022)(Global Blood Therapeutics Inc)
| GBT latest price $45.6000 (1.36%) ($42.2300 - $46.0300) on Fri. Aug. 21, 2015. | |
| | Trend Analysis and Forecast | | | | Average Daily Percentage Swing | 11.43% (three month average) | | RSI | 50 | | Latest Price | $45.6000(1.36%) | | Stocks Behave Similarly | Similar Stock List | | Market Behavior | Broad based sell-off for large cap. Value stock sell-off for small cap. | | Correlated ETFs | Broad market will support GBT advance at 0% a week (0% probability)
XBI(54%) IBB(50%) IWM(37%) XLV(36%) QQQ(35%) | | Factors Impacting GBT price | GBT will decline at least -5.715% in a week (0% probabilities).
VIXM(-16%) TLT(-12%) UUP(-9%) SHY(-6%) IGOV(-3%) | | | | | | | | Relative Volatility | (options are extremely cheap) | | | | | Market Trend Strength | -5.715% (StdDev 11.43%) | | Hourly BBV | 0 () | | Intraday Trend | 3.4% | | | | | |
|
| 5 Day Moving Average | $46.66(-2.27%) | | 10 Day Moving Average | $0(INF%) | | 20 Day Moving Average | $0(INF%) | | To recent high | -14.8% | | To recent low | 16.8% | | Market Cap | $2.797b | | | | | | |
Global Blood Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders. It also provides oral medicines for sickle cell diseases. The company was founded by Matthew P. Jacobson, Andrej Sali, Jack Taunton, Charles J. Homcy, Craig D. Muir and David R. Phillips in February 2011 and is headquartered in South San Francisco, CA. |